Data back IMI's efforts in colorectal, lung and breast cancers
This article was originally published in Clinica
Executive Summary
Canada's IMI International Medical Innovations says that its mucus-based screening tests for lung, colorectal and breast cancers are showing "significant" promise in clinical trials.